Rituximab induced cytokine release with high serum IP-10 (CXCL10) concentrations is associated with infusion reactions

Authors: Moore, Jeremiah E., Bloom, Paige C., Chu, Charles C., Bruno, Jennifer E., Herne, Christine A., Baran, Andrea M., Quataert, Sally A., Mosmann, Timothy R., Taylor, Ronald P., Wallace, Danielle S., Elliott, Michael R., Barr, Paul M., Zent, Clive S.

Source: In Leukemia Research June 2023 129

Rituximab Induces an Inflammatory Cytokine Response with Increased IP-10 (CXCR10) in Patients with Infusion Reactions

Authors: Zent, Clive S., Moore, Jeremiah E. ^*, Bloom, Paige C. ^*, Chu, Charles C., Bruno, Jennifer E. ^*, Herne, Christine A. ^*, Baran, Andrea M ^*, Quataert, Sally A. ^*, Mosmann, Tim R. ^*, Taylor, Ronald P. ^*, Wallace, Danielle S., Elliott, Michael R. ^*, Barr, Paul M.

Source: In Blood 15 November 2022 140 Supplement 1:4171-4172